HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
vasoactive intestinal peptide (10-28)
inhibits VIP stimulation of adenylate cyclase
Also Known As:
VIP (10-28)
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Nerve Tissue Proteins: 2
Neuropeptides: 6772
Vasoactive Intestinal Peptide: 2100
vasoactive intestinal peptide (10-28): 1
Peptides: 82426
Neuropeptides: 6772
Vasoactive Intestinal Peptide: 2100
vasoactive intestinal peptide (10-28): 1
Peptide Hormones: 1347
Vasoactive Intestinal Peptide: 2100
vasoactive intestinal peptide (10-28): 1
Peptide Fragments: 373
vasoactive intestinal peptide (10-28): 1
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Peptide Hormones: 1347
Vasoactive Intestinal Peptide: 2100
vasoactive intestinal peptide (10-28): 1
Gastrointestinal Hormones: 573
Vasoactive Intestinal Peptide: 2100
vasoactive intestinal peptide (10-28): 1
Experts
1.
McCord, Gregg R
: 1 article (12/2005)
2.
Minson, Christopher T
: 1 article (12/2005)
3.
Tublitz, Nathan J
: 1 article (12/2005)
4.
Wilkins, Brad W
: 1 article (12/2005)
5.
Wong, Brett J
: 1 article (12/2005)
Related Diseases
1.
Hyperthermia
12/01/2005 - "
Similarly, H1-receptor antagonists had no effect on the augmented dilation during hyperthermia (P > 0.05 vs. VIP(10-28)).
"